SEROTONIN (5-HT) RECEPTORS AND SALIVARY GLAND FUNCTION
SEROTONIN (5-HT) RECEPTORS AND SALIVARY GLAND FUNCTION
批准号:
6523895
负责人:
GARY Andrew WEISMAN
金额:
$15.41万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-09-30 至 2003-08-31
关键词:
adenylate cyclase biological signal transduction cell aggregation cell type cyclic AMP enzyme activity high performance liquid chromatography immunocytochemistry in situ hybridization laboratory rat membrane transport proteins messenger RNA polymerase chain reaction protein kinase radiotracer receptor coupling receptor expression salivary glands secretion serotonin receptor submandibular gland tissue /cell culture tryptophan 5 monooxygenase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (adapted from the Investigator's abstract): The biogenic amine,
serotonin (5-hydroxytrptamine, [5-HT]) is an important extracellular regulator
in the central nervous system and many peripheral tissues including the
gastrointestinal tract, urinary tract, adrenal cortex, and vasculature.
Published data from the Principal Investigator's laboratory have demonstrated
that, in the intact perfused rat submandibular gland, 5-HT decreases
acetylcholine-induced saliva flow and increases saliva protein content. 5-HT
also increases cAMP production in dispersed SMG (as well as sublingual and
parotid) cell aggregates, but has no effect on SMG cell intracellular free Ca2+
concentrations. The data presented in this proposal suggest that rat SMG
co-expresses two 5-HT receptor subtypes, 5-HT4b and 5-HT7, both of which are
positively coupled to cAMP production. The main hypothesis of this proposal is
that cAMP-coupled 5-HT receptors in the rat SMG play physiological roles in the
regulation of gland function. Such receptors might be potential therapeutic
targets in diseases affecting salivary gland function. The goals of the
research are: 1. To define conclusively the 5-HT receptor complement in rat SMG
in terms of subtypes and receptor density of each subtype using molecular,
pharmacological, and radioligand binding techniques. 2. To determine the
cell-type specific distribution of 5-HT receptor subtypes using functional
assays in dispersed duct and acinar -enriched cell aggregates from SMG in
conjunction with in situ hybridization studies designed to co-localize 5-HT
receptor subtype mRNAs with cell-type specific marker proteins using dual
fluorescence techniques, 3. To verify that the adenyl cyclase-cAMP-cAMP
dependent protein kinase signaling pathway mediates the 5-HT effects in the
SMG, through use of selective pharmacological tools which activate or inhibit
this pathway in conjunction with subtype-specific 5-HTR ligands; and 4. To
begin to assess the physiological relevance of SMG 5-HT receptors by
determining the 5-HT levels in the gland, detecting the key 5-HT synthetic
enzyme in SMG and determining the presence and level of high affinity 5-HT
transporters (SERT) in SMG. Successful completion of these goals will help to
resolve the question of whether 5-HT is one of the growing list of agents
involved in the regulation of mammalian salivary gland function and might
stimulate interest in 5-HT receptors as therapeutic targets in patients with
salivary gland dysfunction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The P2X7 receptor for ATP as a therapeutic target in the prevention of radiation-induced salivary gland dysfunction
-
批准号:10659723
-
项目类别:
-
资助金额:$52.42万
-
财政年份:2023
-
负责人:GARY Andrew WEISMAN
-
依托单位:
Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome
-
批准号:10685136
-
项目类别:
-
资助金额:$5.97万
-
财政年份:2022
-
负责人:GARY Andrew WEISMAN
-
依托单位:
Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome
-
批准号:10554383
-
项目类别:
-
资助金额:$59.46万
-
财政年份:2021
-
负责人:GARY Andrew WEISMAN
-
依托单位:
Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome
-
批准号:10360664
-
项目类别:
-
资助金额:$59.44万
-
财政年份:2021
-
负责人:GARY Andrew WEISMAN
-
依托单位:
Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome
-
批准号:10788973
-
项目类别:
-
资助金额:$11.93万
-
财政年份:2021
-
负责人:GARY Andrew WEISMAN
-
依托单位:
Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome
-
批准号:10219752
-
项目类别:
-
资助金额:$61.16万
-
财政年份:2021
-
负责人:GARY Andrew WEISMAN
-
依托单位:
2017 Salivary Glands and Exocrine Biology Gordon Research Conference & Gordon Research Seminar
-
批准号:9248729
-
项目类别:
-
资助金额:$1.8万
-
财政年份:2016
-
负责人:GARY Andrew WEISMAN
-
依托单位:
Restoring Salivary Gland Function by Reducing Nucleotide-induced Inflammation
-
批准号:8630757
-
项目类别:
-
资助金额:$59.06万
-
财政年份:2013
-
负责人:GARY Andrew WEISMAN
-
依托单位:
Restoring Salivary Gland Function by Reducing Nucleotide-induced Inflammation
-
批准号:9185314
-
项目类别:
-
资助金额:$58.25万
-
财政年份:2013
-
负责人:GARY Andrew WEISMAN
-
依托单位:
The Regulation of Salivary Gland Regeneration by P2Y2 Nucleotide Receptors
-
批准号:7932509
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2009
-
负责人:GARY Andrew WEISMAN
-
依托单位:
CELL, MOLECULAR AND ANIMAL CORE
-
批准号:7192128
-
项目类别:
-
资助金额:$30.8万
-
财政年份:2006
-
负责人:GARY Andrew WEISMAN
-
依托单位:
Novel Mechanisms of Chronic Inflammation in Sjogren's Syndrome
-
批准号:7470577
-
项目类别:
-
资助金额:$32.04万
-
财政年份:2006
-
负责人:GARY Andrew WEISMAN
-
依托单位:
MECHANISMS OF CHRONIC INFLAMMATION AND NEUROPROTECTION IN AD
-
批准号:7192131
-
项目类别:
-
资助金额:$29.08万
-
财政年份:2006
-
负责人:GARY Andrew WEISMAN
-
依托单位:
Novel Mechanisms of Chronic Inflammation in Sjogren's Syndrome
-
批准号:7126558
-
项目类别:
-
资助金额:$33.38万
-
财政年份:2006
-
负责人:GARY Andrew WEISMAN
-
依托单位:
Novel Mechanisms of Chronic Inflammation in Sjogren's Syndrome
-
批准号:7254907
-
项目类别:
-
资助金额:$32.41万
-
财政年份:2006
-
负责人:GARY Andrew WEISMAN
-
依托单位:
Novel Mechanisms of Chronic Inflammation in Sjogren's Syndrome
-
批准号:7658184
-
项目类别:
-
资助金额:$32.03万
-
财政年份:2006
-
负责人:GARY Andrew WEISMAN
-
依托单位:
Novel Mechanisms of Chronic Inflammation in Sjogren's Syndrome
-
批准号:7897916
-
项目类别:
-
资助金额:$31.7万
-
财政年份:2006
-
负责人:GARY Andrew WEISMAN
-
依托单位:
Modular domains, docking sites, conserved binding domains in P2 nucleotide rece
-
批准号:6980128
-
项目类别:
-
资助金额:$0.11万
-
财政年份:2004
-
负责人:GARY Andrew WEISMAN
-
依托单位:
MODULAR DOMAINS, DOCKING SITES, CONSERVED BINDING DOMAINS IN P2 NUCLEOTIDE RECE
-
批准号:7181668
-
项目类别:
-
资助金额:$0.1万
-
财政年份:2004
-
负责人:GARY Andrew WEISMAN
-
依托单位:
STRUC & FUNC: MOD DOMAINS, DOCK SITES, CONSERVED BINDING IN P2 NUCLEOTIDE RECEPT
-
批准号:6319819
-
项目类别:
-
资助金额:$0.13万
-
财政年份:1999
-
负责人:GARY Andrew WEISMAN
-
依托单位:--
海外基金